홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Lidocaine Hydrochloride

HCID 6314
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
6108-05-0
표준 SMILES
CCN(CC)CC(=O)Nc1c(C)cccc1C.Cl
InChIKey
IYBQHJMYDGVZRY-UHFFFAOYSA-N
분자식
C14H23ClN2O
평균 분자량
270.8 g/mol
단동위원소 질량
270.14989104

개요

Lidocaine Hydrochloride is the hydrochloride salt form of lidocaine, an aminoethylamide and a prototypical member of the amide class anesthetics. Lidocaine interacts with voltage-gated Na+ channels in the nerve cell membrane and blocks the transient increase in permeability of excitable membranes to Na+. This prevents the generation and conduction of nerve impulses and produces a reversible loss of sensation. Lidocaine hydrochloride also exhibits class IB antiarrhythmic effects. The agent decreases the flow of sodium ions into myocardial tissue, especially on the Purkinje network, during phase 0 of the action potential, thereby decreasing depolarization, automaticity and excitability.

이름 및 식별자

우선 이름
Lidocaine Hydrochloride
IUPAC
2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
영어명
Lidocaine hydrochloride
분자식
C14H25ClN2O2
분자량
288.82

이름 및 동의어

Lidocaine hydrochloride73-78-9LIDOCAINE HCLLidothesinLignocaine hydrochlorideLaryng-O-jetAnestaconLidocatonGlydoXylocaine ViscousLIDOCAINE VISCOUSLTA II KIT
이름 더 보기
LINOCAINE HYDROCHLORIDELINOCAINE HCLLinocaine hydrochlorLinocaine hydrochloride monohydrateLignocaine hydrochloride monohydrateLinocaine hydrochloride(lidocaine HCL)2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide hydrochloride hydrate2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide hydrate hydrochlorideACETAMIDE,2-(DIETHYLAMINO)-N-(2,6-DIMETHYLPHENYL)-MONOHYDROCHLORIDE, MONOHYDRATEdolicaine
PEDIATRIC LTA KITLARYNG-O-JET KITLidocaine hydrochloride anhydrousLIDOPENZingoEC2CNF7XFPXYLOCAINE PRESERVATIVE FREELARYNGOTRACHEAL ANESTHESIA KIT

데이터베이스 식별자

물성

구조 계산 물성

극성 표면적
32.3 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
2
회전 가능 결합 수
5
무거운 원자 수
18
형식 전하
0
복잡도
228

실험 및 물리화학적 성질

Human Drugs · 3건

Breast Feeding; Lactation; Milk, Human; Antiarrhythmics; Local Anesthetics

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section155.4 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
75 · 75-79℃
저장 조건
2 · 2-8°C
용해도
2 O: · H2O: 용해성
물리적 상태
고체
색상
하얀색
수용성
물(50 mg/ml), 클로로포름, 에탄올 및 벤젠에 용해됩니다. 디에틸 에테르에 불용성.
주요 응용
의약품(소분자)
InChI
InChI=1S/C14H22N2O.ClH.H2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4;;/h7-9H,5-6,10H2,1-4H3,(H,15,17);1H;1H2
InChIKey
YECIFGHRMFEPJK-UHFFFAOYSA-N
SMILES
C1(C(C)=CC=CC=1C)NC(=O)CN(CC)CC.O.Cl
LogP
2.359 · 2.359 (est)
화학적 성질 · 1건

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 6건

Danger

H301 (82.5%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P301+P317, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 183 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

H301 (46.3%): Toxic if swallowed [Danger Acute toxicity, oral]

유해성 정보

Regulatory InformationLidocaine hydrochloride: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, monohydrochloride: Environment tier I assessment
Hazard Classes and Categories · 2건

Acute Tox. 3 (46.3%)

Acute Tox. 3 (82.5%)

독성 정보

Treatment · 1건

The first step in the management of systemic toxic reactions consists of immediate attention to the establishment and maintenance of a patent airway and assisted or controlled ventilation with oxygen and a delivery system capable of permitting immediate positive airway pressure by mask. If convulsions occur, the objective of the treatment is to maintain ventilation and oxygenation and support the circulation. Oxygen must be given and ventilation assisted if necessary (mask and bag or tracheal intubation). Should convulsions not stop spontaneously after 15-20 seconds, an anticonvulsant should be given i.v. to facilitate adequate ventilation and oxygenation. Thiopental sodium 1-3 mg/kg i.v. is the first choice. Alternatively diazepam 0.1 mg/kg bw i.v. may be used, although its action will be slow. Prolonged convulsions may jeopardise the patient's ventilation and oxygenation. If so, injection of a muscle relaxant (e.g. succinylcholine 1 mg/kg bw) will facilitate ventilation, and oxygenation can be controlled. Early endotracheal intubation must be considered in such situations. If cardiovascular depression is evident (hypotension, bradycardia), ephedrine 5-10 mg i.v. should be given and may be repeated, if necessary, after 2-3 minutes. Should circulatory arrest occur, immediate cardiopulmonary resuscitation should be instituted. Continual oxygenation and ventilation and circulatory support as well as treatment of acidosis are of vital importance. (L1712)

화학 및 산업

약리 정보

Metabolism/MetabolitesPrimarily hepatic. Route of Elimination: Lidocaine and its metabolites are excreted by the kidneys. Half Life: 109 minutes
FDA Pharmacological Classification · 6건

0.5% LIDOCAINE HCL

Local Anesthesia [PE]; Antiarrhythmic [EPC]; Amide Local Anesthetic [EPC]; Amides [CS]

1% LIDOCAINE HCI

Local Anesthesia [PE]; Amide Local Anesthetic [EPC]; Antiarrhythmic [EPC]; Amides [CS]

2% LIDOCAINE HCI

Local Anesthesia [PE]; Antiarrhythmic [EPC]; Amide Local Anesthetic [EPC]; Amides [CS]

MeSH Pharmacological Classification · 3건

Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS.

용도 및 제조

Uses · 1건

For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.

관련 반응

9건
반응 기록 만들기
HRID 240241 반응식
HRID 240241반응물로
HRID 240242 반응식
HRID 240242반응물로
HRID 240243 반응식
HRID 240243반응물로
HRID 342317 반응식
HRID 342317생성물로반응물로
HRID 362738 반응식
HRID 362738생성물로반응물로
HRID 1517223 반응식
HRID 1517223반응물로
HRID 1585955 반응식
HRID 1585955생성물로반응물로
HRID 2191206 반응식
HRID 2191206생성물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
CAS
6108-05-0、73-78-9
PubChem CID
6314
DTXSID
DTXSID4058782
ChEMBL
CHEMBL1200409、CHEMBL541521
UNII
EC2CNF7XFP
EC Number
200-803-8、612-079-4

Linocaine hydrochloride is a white or almost white, crystalline powder with slightly bitter and numbing taste. Soluble in water, ethanol and organic solvents, insoluble in ether. The aqueous solution does not decompose under acid and alkali conditions, and it rarely deteriorates after repeated autoclaving.

Health Effects · 1건

Systemic exposure to excessive quantities of lidocaine mainly result in central nervous system (CNS) and cardiovascular effects. CNS effects may include CNS excitation(nervousness, tingling around the mouth) followed by depression. [Wikipedia]

Exposure Routes · 1건

Intravenous, Topical, Oral, Buccal, Dental, Intramuscular, or Urethral injection , Infiltration. Information derived from diverse formulations, concentrations and usages reveals that lidocaine is completely absorbed following parenteral administration, its rate of absorption depending, for example, upon various factors such as the site of administration and the presence or absence of a vasoconstrictor agent.

Toxicity Summary · 1건

Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action. Lidocaine alters signal conduction in neurons by blocking the fast voltage gated sodium (Na+) channels in the neuronal cell membrane that are responsible for signal propagation. With sufficient blockage the membrane of the postsynaptic neuron will not depolarize and will thus fail to transmit an action potential. This creates the anaesthetic effect by not merely preventing pain signals from propagating to the brain but by aborting their birth in the first place.

Signs and SymptomsSymptoms of overdose include convulsions, hypoxia, acidosis, bradycardia, arrhythmias and cardiac arrest.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Toxicity DataLD50: 459 (346-773) mg/kg (oral, non-fasted female rats) LD50: 214 (159-324) mg/kg (oral, fasted female rats)

안전 데이터

wgk
3
tsca
Yes
rtecs
AN7700000
ridadr
UN 2811 6.1/PG 3
HS 번호
2924296000
risk_code
22
hazard_code
Xn
safety_code
36
위험 등급
6.1
Hazard Classifications
Acute Tox. 3 Oral
스토리지 클래스
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Household ProductsInformation on 1 consumer products that contain Lidocaine hydrochloride in the following categories is provided:
General Manufacturing InformationAcetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, hydrochloride (1:1): ACTIVE
응용 분야 · 1건

용도Linocaine hydrochloride is a fast voltage-gated sodium channel blocker that used in Local anesthesia and heart rhythm disorders. Its actions are more intense and its effects more prolonged than those of procaine but its duration of action is shorter than that of bupivacaine or prilocaine.

추가 설명 · 1건

정의ChEBI: Linocaine hydrochloride is the monohydrate form of lidocaine hydrochloride. It is a local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of Procaine but its duration of action is shorter than that of bupivacaine or prilocaine.